- Home
- IMRX vs ENX Comparison
IMRX vs ENX Comparison
Compare IMRX & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- ENX
- Stock Information
- Founded
- IMRX 2008
- ENX 2002
- Country
- IMRX United States
- ENX United States
- Employees
- IMRX 54
- ENX N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- ENX Finance/Investors Services
- Sector
- IMRX Health Care
- ENX Finance
- Exchange
- IMRX Nasdaq
- ENX Nasdaq
- Market Cap
- IMRX 145.7M
- ENX 165.4M
- IPO Year
- IMRX 2021
- ENX N/A
- Fundamental
- Price
- IMRX $4.24
- ENX $9.21
- Analyst Decision
- IMRX Strong Buy
- ENX
- Analyst Count
- IMRX 4
- ENX 0
- Target Price
- IMRX $13.25
- ENX N/A
- AVG Volume (30 Days)
- IMRX 3.1M
- ENX 25.4K
- Earning Date
- IMRX 08-05-2025
- ENX 01-01-0001
- Dividend Yield
- IMRX N/A
- ENX 3.94%
- EPS Growth
- IMRX N/A
- ENX N/A
- EPS
- IMRX N/A
- ENX 0.16
- Revenue
- IMRX N/A
- ENX N/A
- Revenue This Year
- IMRX N/A
- ENX N/A
- Revenue Next Year
- IMRX N/A
- ENX N/A
- P/E Ratio
- IMRX N/A
- ENX $61.00
- Revenue Growth
- IMRX N/A
- ENX N/A
- 52 Week Low
- IMRX $1.00
- ENX $7.84
- 52 Week High
- IMRX $4.60
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- IMRX 77.22
- ENX 44.65
- Support Level
- IMRX $3.31
- ENX $9.24
- Resistance Level
- IMRX $4.60
- ENX $9.34
- Average True Range (ATR)
- IMRX 0.43
- ENX 0.09
- MACD
- IMRX 0.12
- ENX 0.00
- Stochastic Oscillator
- IMRX 96.10
- ENX 26.09
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.